Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133441) titled 'Response-guided neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma' on Sept. 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai East Hospital
Condition:
Locally advanced resectable thoracic esophageal squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-01
Target Sample Size: Response-guided neoadjuvant therapy group:37;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345392
Published by HT Digital Content Services with...